SCHEMBL17876288

SCHEMBL17876288

c1ccc(N2Cc3ccc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)cc3-c3cc(-n4c5ccccc5c5ccccc54)ccc3C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.39
PIM3 Q86V86 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
CYP11B1 P15538 8/20 0.38
CYP11B2 P19099 7/20 0.38
TDP2 O95551 2/20 0.38
CYP19A1 P11511 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP17A1 P05093 2/20 0.37
MAPT P10636 3/20 0.36
GBA1 P04062 1/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876265 0.95 CYP11B2 (0.39) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17876221 0.95 PIM1 (0.37) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17877880 0.90 CYP11B2 (0.41) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17876286 0.89 KDM4E (0.41) MAPTKDM4EATML3MBTL1MEN1
SCHEMBL17876317 0.88 KDM4E (0.37) PIM1PIM3MAPTKDM4EATM
SCHEMBL17876310 0.88 CYP11B2 (0.48) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17876313 0.87 TDP2 (0.48) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17877875 0.86 CYP11B2 (0.40) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17876225 0.86 CYP11B2 (0.40) PIM1PIM3PIM2CYP11B1CYP11B2
SCHEMBL17875884 0.86 CYP11B1 (0.40) PIM1PIM3PIM2CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PIM1 3767/4885PIM3 3628/4885PIM2 4398/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PIM1 3767/4885PIM3 3628/4885PIM2 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.